165 related articles for article (PubMed ID: 8986534)
1. Expression of epidermal growth factor-related proteins and epidermal growth factor receptor in common epithelial ovarian tumors.
Niikura H; Sasano H; Sato S; Yajima A
Int J Gynecol Pathol; 1997 Jan; 16(1):60-8. PubMed ID: 8986534
[TBL] [Abstract][Full Text] [Related]
2. Immunolocalization of epidermal growth factor receptor and c-erbB-2 oncogene product in human ovarian carcinoma.
Ito K; Sasano H; Ozawa N; Sato S; Silverberg SG; Yajima A
Int J Gynecol Pathol; 1992 Oct; 11(4):253-7. PubMed ID: 1356938
[TBL] [Abstract][Full Text] [Related]
3. Frequent immunohistochemical detection of EGF supergene family members in ovarian carcinogenesis.
Stromberg K; Johnson GR; O'Connor DM; Sorensen CM; Gullick WJ; Kannan B
Int J Gynecol Pathol; 1994 Oct; 13(4):342-7. PubMed ID: 7814196
[TBL] [Abstract][Full Text] [Related]
4. Expression of epidermal growth factor family proteins and epidermal growth factor receptor in human endometrium.
Niikura H; Sasano H; Kaga K; Sato S; Yajima A
Hum Pathol; 1996 Mar; 27(3):282-9. PubMed ID: 8600044
[TBL] [Abstract][Full Text] [Related]
5. Significance of tyrosine kinase activity on malign transformation of ovarian tumors: a comparison between EGF-R and TGF-alpha.
Zeren T; Inan S; Seda Vatansever H; Ekerbicer N; Sayhan S
Acta Histochem; 2008; 110(3):256-63. PubMed ID: 18054376
[TBL] [Abstract][Full Text] [Related]
6. Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters.
Lin CK; Su HY; Tsai WC; Sheu LF; Jin JS
Dis Markers; 2008; 25(1):17-26. PubMed ID: 18776588
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of oncogenes and growth factors in ovarian carcinomas.
Bauknecht T; Birmelin G; Kommoss F
J Steroid Biochem Mol Biol; 1990 Dec; 37(6):855-62. PubMed ID: 2285597
[TBL] [Abstract][Full Text] [Related]
8. SATB2 Expression Distinguishes Ovarian Metastases of Colorectal and Appendiceal Origin From Primary Ovarian Tumors of Mucinous or Endometrioid Type.
Moh M; Krings G; Ates D; Aysal A; Kim GE; Rabban JT
Am J Surg Pathol; 2016 Mar; 40(3):419-32. PubMed ID: 26551622
[TBL] [Abstract][Full Text] [Related]
9. Impact of the expression of epidermal growth factor, transforming growth factor alpha, and epidermal growth factor receptor on the prognosis of superficial bladder cancer.
Türkeri LN; Erton ML; Cevik I; Akdaş A
Urology; 1998 Apr; 51(4):645-9. PubMed ID: 9586623
[TBL] [Abstract][Full Text] [Related]
10. Stage-specific embryonic antigen 4 expression in epithelial ovarian carcinoma.
Ye F; Li Y; Hu Y; Zhou C; Hu Y; Chen H
Int J Gynecol Cancer; 2010 Aug; 20(6):958-64. PubMed ID: 20683402
[TBL] [Abstract][Full Text] [Related]
11. Mitogenic effects of epidermal growth factor and transforming growth factor-alpha on EGF-receptor positive human ovarian carcinoma cell lines.
Crew AJ; Langdon SP; Miller EP; Miller WR
Eur J Cancer; 1992; 28(2-3):337-41. PubMed ID: 1591048
[TBL] [Abstract][Full Text] [Related]
12. Expression of the imprinted H19 oncofetal RNA in epithelial ovarian cancer.
Tanos V; Prus D; Ayesh S; Weinstein D; Tykocinski ML; De-Groot N; Hochberg A; Ariel I
Eur J Obstet Gynecol Reprod Biol; 1999 Jul; 85(1):7-11. PubMed ID: 10428315
[TBL] [Abstract][Full Text] [Related]
13. Occurrence of epidermal growth factor receptors in benign and malignant ovarian tumors and normal ovarian tissues: an immunohistochemical study.
Henzen-Logmans SC; van der Burg ME; Foekens JA; Berns PM; Brussée R; Fieret JH; Klijn JG; Chadha S; Rodenburg CJ
J Cancer Res Clin Oncol; 1992; 118(4):303-7. PubMed ID: 1315781
[TBL] [Abstract][Full Text] [Related]
14. Ki-67 staining in benign, borderline, malignant primary and metastatic ovarian tumors: correlation with steroid receptors, epidermal-growth-factor receptor and cathepsin D.
Henzen-Logmans SC; Fieret EJ; Berns EM; van der Burg ME; Klijn JG; Foekens JA
Int J Cancer; 1994 May; 57(4):468-72. PubMed ID: 8181851
[TBL] [Abstract][Full Text] [Related]
15. The expression of six biomarkers in the four most common ovarian cancers: correlation with clinicopathological parameters.
Lin CK; Chao TK; Yu CP; Yu MH; Jin JS
APMIS; 2009 Mar; 117(3):162-75. PubMed ID: 19245589
[TBL] [Abstract][Full Text] [Related]
16. Ovarian mature teratomas with mucinous epithelial neoplasms: morphologic heterogeneity and association with pseudomyxoma peritonei.
McKenney JK; Soslow RA; Longacre TA
Am J Surg Pathol; 2008 May; 32(5):645-55. PubMed ID: 18344868
[TBL] [Abstract][Full Text] [Related]
17. p63 expression in epithelial ovarian tumors.
Poli Neto OB; Candido Dos Reis FJ; Zambelli Ramalho LN; Nogueira AA; de Andrade JM
Int J Gynecol Cancer; 2006; 16(1):152-5. PubMed ID: 16445626
[TBL] [Abstract][Full Text] [Related]
18. Telomerase activity in benign and malignant epithelial ovarian tumors.
Wan M; Li WZ; Duggan BD; Felix JC; Zhao Y; Dubeau L
J Natl Cancer Inst; 1997 Mar; 89(6):437-41. PubMed ID: 9091645
[TBL] [Abstract][Full Text] [Related]
19. Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importance.
Wamunyokoli FW; Bonome T; Lee JY; Feltmate CM; Welch WR; Radonovich M; Pise-Masison C; Brady J; Hao K; Berkowitz RS; Mok S; Birrer MJ
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):690-700. PubMed ID: 16467078
[TBL] [Abstract][Full Text] [Related]
20. Imbalanced expression of inhibin and activin subunits in primary epithelial ovarian cancer.
Zheng W; Luo MP; Welt C; Lambert-Messerlian G; Sung CJ; Zhang Z; Ying SY; Schneyer AL; Lauchlan SC; Felix JC
Gynecol Oncol; 1998 Apr; 69(1):23-31. PubMed ID: 9570994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
